Blueberry Diagnostics

📍 Wilmington, United States🗓 Founded 2019👥 10 employees💰 Last funded Dec 2021
We are here to redefine and revolutionize the cancer paradigm by creating innovative solutions that empower healthcare professionals around the world. Cancer is a shared enemy of our society and transforming its detection will enable us to save millions of lives. At Blueberry Diagnostics, we lead cancer detection with a groundbreaking set of early cancer detection and diagnosis confirmation tests (Laboratory Developed Tests – LDTs), based on routine blood and urine analyses and powered by our Deep Learning (DL) algorithms that deliver unprecedented rates of accuracy and magnificent advantages for all involved stakeholders. Our state-of-the-art solutions masterfully integrate the principles of scientific methodology to deliver outstanding cancer testing sensitivity and specificity. They rely on solid evidence and data, and the technological knowledge that leverages our own developed AI-powered algorithms to maximize the accuracy and efficiency of every test. We are setting the new gold standard for cancer detection. Because early detection saves lives.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Blueberry Diagnostics?
Blueberry Diagnostics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Blueberry Diagnostics last raise funding?
The most recent investment in Blueberry Diagnostics recorded on gritt.io was in December 2021.
When was Blueberry Diagnostics founded?
Blueberry Diagnostics was founded in 2019.
What industry is Blueberry Diagnostics in?
Blueberry Diagnostics operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is Blueberry Diagnostics based?
Blueberry Diagnostics is headquartered in Wilmington, United States.